Literature DB >> 21956280

Clinical characteristics and prognosis of nontuberculous mycobacterial lung disease with different radiographic patterns.

Chin-Chung Shu1, Chih-Hsin Lee, Chia-Lin Hsu, Jann-Tay Wang, Jann-Yuan Wang, Chong-Jen Yu, Li-Na Lee.   

Abstract

RATIONALE: The clinical characteristics and prognostic impact of radiographic patterns of patients with nontuberculous mycobacterial lung disease (NTM-LD) are rarely evaluated.
DESIGN: Patients with NTM-LD from 2007 to 2009 in a single medical center in Taiwan were identified. Their radiographic patterns were reviewed and classified into cavitary, bronchiectatic, or consolidative. They were also compared to patients with cavitary pulmonary tuberculosis (TB-LD).
RESULTS: Of 481 NTM-LD patients identified, 62, 134, and 56 patients were categorized into cavitary, bronchiectatic, and consolidative groups, respectively. Compared with 180 TB-LD patients, cavitary NTM-LD had male predominance and was associated with higher grades of sputum acid-fast smear (3+ or 4+), prior pulmonary TB, and poor baseline pulmonary function. NTM-LD patients with consolidative pattern were likely to have underlying comorbidity, the highest blood leukocyte count and C-reactive protein, and lowest albumin. In all NTM-LD, the consolidative pattern was independently associated with poor prognosis for 6-month survival. Patients with cavitary Mycobacterium avium complex (MAC)-LD had worse 6-month survival than those with bronchiectatic pattern.
CONCLUSION: In Taiwan, NTM-LD patients with consolidative pattern have the worst prognosis while patients with cavitary pattern have worse survival than those with bronchiectasis in MAC-LD. Because varying radiographic patterns represent different prognoses, understanding the characteristics of NTM-LD patients with different radiographic patterns complements clinical practice.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21956280     DOI: 10.1007/s00408-011-9321-4

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  28 in total

1.  Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.

Authors:  D Rebecca Prevots; Pamela A Shaw; Daniel Strickland; Lisa A Jackson; Marsha A Raebel; Mary Ann Blosky; Ruben Montes de Oca; Yvonne R Shea; Amy E Seitz; Steven M Holland; Kenneth N Olivier
Journal:  Am J Respir Crit Care Med       Date:  2010-06-10       Impact factor: 21.405

Review 2.  Chest radiographic and CT manifestations of chronic granulomatous disease in adults.

Authors:  Myrna C B Godoy; Patrick M Vos; Peter L Cooperberg; Carmen P Lydell; Peter Phillips; Nestor L Müller
Journal:  AJR Am J Roentgenol       Date:  2008-11       Impact factor: 3.959

3.  Nontuberculous mycobacterial lung infections in Ontario, Canada: clinical and microbiological characteristics.

Authors:  Theodore K Marras; Mauli Mehta; Pamela Chedore; Kevin May; Mohammed Al Houqani; Frances Jamieson
Journal:  Lung       Date:  2010-04-11       Impact factor: 2.584

4.  Non-tuberculous mycobacterial pleurisy: an 8-year single-centre experience in Taiwan.

Authors:  C-C Shu; L-N Lee; J-T Wang; Y-J Chien; J-Y Wang; C-J Yu
Journal:  Int J Tuberc Lung Dis       Date:  2010-05       Impact factor: 2.373

5.  Pulmonary TB and NTM lung disease: comparison of characteristics in patients with AFB smear-positive sputum.

Authors:  W J Koh; C M Yu; G Y Suh; M P Chung; H Kim; O J Kwon; N Y Lee; M J Chung; K S Lee
Journal:  Int J Tuberc Lung Dis       Date:  2006-09       Impact factor: 2.373

6.  Non-tuberculous mycobacteria: patterns of isolation. A multi-country retrospective survey.

Authors:  N Martín-Casabona; A R Bahrmand; J Bennedsen; V Ostergaard Thomsen; M Curcio; M Fauville-Dufaux; K Feldman; M Havelkova; M L Katila; K Köksalan; M F Pereira; F Rodrigues; G E Pfyffer; F Portaels; J Rosselló Urgell; S Rüsch-Gerdes; E Tortoli; V Vincent; B Watt
Journal:  Int J Tuberc Lung Dis       Date:  2004-10       Impact factor: 2.373

7.  Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome.

Authors:  Richard D Kim; David E Greenberg; Mary E Ehrmantraut; Shireen V Guide; Li Ding; Yvonne Shea; Margaret R Brown; Milica Chernick; Wendy K Steagall; Connie G Glasgow; JingPing Lin; Clara Jolley; Lynn Sorbara; Mark Raffeld; Suvimol Hill; Nilo Avila; Vandana Sachdev; Lisa A Barnhart; Victoria L Anderson; Reginald Claypool; Dianne M Hilligoss; Mary Garofalo; Alan Fitzgerald; Sandra Anaya-O'Brien; Dirk Darnell; Rosamma DeCastro; Heather M Menning; Stacy M Ricklefs; Stephen F Porcella; Kenneth N Olivier; Joel Moss; Steven M Holland
Journal:  Am J Respir Crit Care Med       Date:  2008-08-14       Impact factor: 21.405

Review 8.  Nontuberculous mycobacterial pulmonary disease.

Authors:  Margaret M Johnson; Ernest Andrew Waller; Jack P Leventhal
Journal:  Curr Opin Pulm Med       Date:  2008-05       Impact factor: 3.155

9.  Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea.

Authors:  Won-Jung Koh; O Jung Kwon; Kyeongman Jeon; Tae Sung Kim; Kyung Soo Lee; Young Kil Park; Gill Han Bai
Journal:  Chest       Date:  2006-02       Impact factor: 9.410

10.  Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand.

Authors:  Ploenchan Chetchotisakd; Sasisopin Kiertiburanakul; Piroon Mootsikapun; Susun Assanasen; Romanee Chaiwarith; Siriluck Anunnatsiri
Journal:  Clin Infect Dis       Date:  2007-07-05       Impact factor: 9.079

View more
  21 in total

1.  Mortality among patients with pulmonary non-tuberculous mycobacteria disease.

Authors:  M Fleshner; K N Olivier; P A Shaw; J Adjemian; S Strollo; R J Claypool; L Folio; A Zelazny; S M Holland; D R Prevots
Journal:  Int J Tuberc Lung Dis       Date:  2016-05       Impact factor: 2.373

2.  Mortality after Respiratory Isolation of Nontuberculous Mycobacteria. A Comparison of Patients Who Did and Did Not Meet Disease Criteria.

Authors:  Shannon A Novosad; Emily Henkle; Sean Schafer; Katrina Hedberg; Jennifer Ku; Sarah A R Siegel; Dongseok Choi; Christopher G Slatore; Kevin L Winthrop
Journal:  Ann Am Thorac Soc       Date:  2017-07

Review 3.  Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review.

Authors:  D Rebecca Prevots; Theodore K Marras
Journal:  Clin Chest Med       Date:  2014-11-06       Impact factor: 2.878

4.  Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Eur Respir J       Date:  2020-07-07       Impact factor: 16.671

5.  Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.

Authors:  Charles L Daley; Jonathan M Iaccarino; Christoph Lange; Emmanuelle Cambau; Richard J Wallace; Claire Andrejak; Erik C Böttger; Jan Brozek; David E Griffith; Lorenzo Guglielmetti; Gwen A Huitt; Shandra L Knight; Philip Leitman; Theodore K Marras; Kenneth N Olivier; Miguel Santin; Jason E Stout; Enrico Tortoli; Jakko van Ingen; Dirk Wagner; Kevin L Winthrop
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

Review 6.  Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis.

Authors:  Giulia Bonaiti; Alberto Pesci; Almerico Marruchella; Giuseppe Lapadula; Andrea Gori; Stefano Aliberti
Journal:  Biomed Res Int       Date:  2015-05-27       Impact factor: 3.411

7.  Factors associated with lung function decline in patients with non-tuberculous mycobacterial pulmonary disease.

Authors:  Meng-Rui Lee; Ching-Yao Yang; Kai-Ping Chang; Li-Ta Keng; David Hung-Tsang Yen; Jann-Yuan Wang; Huey-Dong Wu; Li-Na Lee; Chong-Jen Yu
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

8.  Increased risk of active tuberculosis following acute kidney injury: a nationwide, population-based study.

Authors:  Vin-Cent Wu; Chen-Yi Wang; Chih-Chung Shiao; Chia-Hsui Chang; Hui-Yu Huang; Tao-Min Huang; Chun-Fu Lai; Meng-Chun Lin; Wen-Je Ko; Kwan-Dun Wu; Chong-Jen Yu; Chin-Chung Shu; Chih-Hsin Lee; Jann-Yuan Wang
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

9.  Sero-diagnosis of Mycobacterium avium complex lung disease using serum immunoglobulin A antibody against glycopeptidolipid antigen in Taiwan.

Authors:  Chin-Chung Shu; Manabu Ato; Jann-Tay Wang; Ruwen Jou; Jann-Yuan Wang; Kazuo Kobayashi; Hsin-Chih Lai; Chong-Jen Yu; Li-Na Lee; Kwen-Tay Luh
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

10.  Nontuberculous mycobacterial infection is associated with increased respiratory failure: a nationwide cohort study.

Authors:  Jun-Jun Yeh; Yu-Chiao Wang; Cheng-Li Lin; Christine Yi-Ting Chou; Ting-Chun Yeh; Bing-Tsang Wu; Fung-Chang Sung; Chia-Hung Kao
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.